ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,048.42
      -0.46%
      US Tech 100
      17,135.20
      0.93%
      Dow Jones
      38,085.80
      -0.98%
      Brent Oil
      88.28
      0.15%
      Bitcoin
      64,400.80
      -0.13%
      Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Veru Inc (VERU)

      7. Veru Inc (VERU) News

      VERU Veru Inc

      1.21
      0.00 (0.00%)
      Pre Market
      Last Updated: 05:26:29
      Delayed by 15 minutes
      Company Name Stock Ticker Symbol Market Type
      Veru Inc VERU NASDAQ Common Stock
        Price Change Change Percent Stock Price Last Traded
      Upgrade Icon
      0.00 0.00% 1.21 05:26:29
      Open Price Low Price High Price Close Price Prev Close
      1.21
      more quote information »

      Recent News

      Date Time Source Heading
      4/25/20248:52IHNWFeaturedCannabix's Breath Logix Alcohol Device Delivers Positive Impact to Private Monitoring Agency in Montana, USA
      4/25/202408:30GLOBEVeru to Present at the American Association of Clinical..
      4/01/202416:05GLOBEVeru Announces Date of 2024 Annual Meeting of Shareholders
      3/22/202416:05GLOBEVeru Reschedules Annual Meeting of Shareholders
      3/12/202408:00GLOBEVeru Announces the Appointment of Louis Aronne MD as Chief..
      2/27/202419:15GLOBEVeru Announces Notification from Nasdaq Related to Delayed..
      2/20/202408:30GLOBEVeru Announces New Scientific Advisory Board for its..
      2/15/202416:49EDGAR2Form NT 10-Q - Notification of inability to timely file Form..
      2/15/202416:06EDGAR2Form 8-K - Current report
      2/14/202416:32EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
      2/08/202407:00EDGAR2Form 8-K - Current report
      2/08/202406:30GLOBEVeru Reports Fiscal 2024 First Quarter Financial Highlights
      2/06/202416:27EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
      2/06/202408:30GLOBEVeru Announces FDA Clearance of IND Application to Initiate..
      1/31/202408:30GLOBEVeru to Present at the Oppenheimer 34th Annual Healthcare..
      1/26/202416:06EDGAR2Form 8-K - Current report
      1/26/202409:02EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
      1/26/202409:00EDGAR2Form DEF 14A - Other definitive proxy statements
      1/25/202408:30GLOBEVeru to Report Fiscal 2024 First Quarter Financial Results..
      1/08/202408:30GLOBEVeru Submits IND Application to FDA for the Development of..
      12/26/202316:31EDGAR2Form SC 13G - Statement of acquisition of beneficial..
      12/19/202308:30GLOBEVeru to Host Investor Call on January 4th, 2024 to Discuss..
      12/18/202309:01EDGAR2Form 8-K - Current report
      12/15/202316:04EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
      12/14/202309:00GLOBEVeru Announces Pricing of Public Offering of Common Stock
      12/13/202316:23EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
      12/13/202316:06EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
      12/13/202316:04EDGAR2Form 8-K - Current report
      12/13/202316:01GLOBEVeru Announces Proposed Public Offering of Common Stock
      12/08/202316:02EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
      12/08/202314:30EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
      11/17/202318:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      11/17/202317:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      11/17/202317:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      11/17/202317:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      11/15/202316:54EDGAR2Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]:..
      11/15/202316:50EDGAR2Form 8-K - Current report
      10/04/202308:30GLOBEVeru Reports Muscle Data from 5 Clinical Studies of..
      10/02/202317:23EDGAR2Form 8-K - Current report
      9/28/202316:22EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
      9/26/202308:30GLOBEVeru Reaches Agreement with FDA on New Phase 3 Clinical..
      9/20/202308:30GLOBEVeru to Participate in Fireside Chat at the 2023 Cantor..
      9/11/202307:00EDGAR2Form 8-K - Current report
      9/11/202307:00GLOBEVeru Reports Clinical Data from the Discontinued ARTEST..
      8/30/202308:30GLOBEVeru to Present at the H.C. Wainwright 25th Annual Global..
      8/10/202312:53EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
      8/10/202307:00EDGAR2Form 8-K - Current report
      8/10/202306:30GLOBEVeru Reports Fiscal 2023 Third Quarter Financial Results
      8/03/202308:30GLOBEVeru to Report Fiscal 2023 Third Quarter Financial Results..
      7/28/202316:09EDGAR2Form 8-K - Current report
      6/21/202308:30GLOBEVeru Inc.’s Oncology Drug Research Program Partner, The..

      Your Recent History

      NASDAQ
      VERU
      Veru
      Delayed Upgrade Clock